Opening on September 1st 2023, the QV Healthcare Practitioner Student Scholarship will award a total of $30,000 in prize money to undergraduate and postgraduate students in Pharmacy, Medicine or Nursing courses in a bid to further the education of the next generation of Australian healthcare practitioners.
Entrants are asked to complete a short essay related to sensitive skin, an area QV understands well having spent decades specialising in skincare for sensitive and problematic skin. Submissions will be judged by a panel of industry experts including Fabrizio Spada (Scientific Affairs Manager, Ego Pharmaceuticals) and Cheryl Talent (President, Eczema Association of Australasia).
QV Skincare, part of the Ego Pharmaceuticals portfolio, has a long and close association with healthcare practitioners since the business was first founded following a request from the dermatology ward of Melbourne’s iconic Queen Victoria Hospital.
Decades on, the QV brand remains family owned, Australian made, and synonymous with quality and innovation. With over 50 QV products sold in more than 20 nations around the world, QV is proud to be the #1 recommended sensitive skincare brand by healthcare practitioners^, a testament to the trust dermatologists, GPs and pharmacists have in the brand.
The QV Healthcare Practitioner Student Scholarship is open from September 1st until September 30th 2023. Interested parties can enter via www.qvskincare.com.au/scholarship.html
For all media enquiries, please contact Ego Pharmaceuticals:
Laura Lock | [email protected] | +61 438 763 996
QV Healthcare Practitioner Student Scholarship Back For 2023
QV Skincare < 1 mins readMedia
More from this category
- Medical Health Aged Care
- 17/12/2025
- 13:11
GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners
300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…
- Contains:
- Finance Investment, Medical Health Aged Care
- 17/12/2025
- 12:03
LTR Pharma surpasses 1,000 SPONTAN® prescriptions under TGA Special Access Scheme
Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…
- Contains:
- Engineering, Medical Health Aged Care
- 17/12/2025
- 09:02
UNSW students claim victory in international artificial heart competition
A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…
- Contains:
Media Outreach made fast, easy, simple.
Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.